Pensionfund Sabic’s Regeneron Pharmaceuticals REGN Stock Holding History

Pensionfund Sabic’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,800	Closed	-$1.66M	–	209
2022 Q2	$1.66M	Sell	2,800 -500	-15%	-$325K	0.53%	69
2022 Q1	$2.31M	Sell	3,300 -900	-21%	-$569K	0.57%	50
2021 Q4	$2.65M	Hold	4,200	–	–	0.5%	81
2021 Q3	$2.54M	Buy	+4,200	New	+$2.61M	0.54%	68
2019 Q2	–	Sell	-4,000	Closed	-$1.64M	–	221
2019 Q1	$1.64M	Sell	4,000 -1,000	-20%	-$412K	0.52%	90
2018 Q4	$1.87M	Buy	+5,000	New	+$1.83M	0.57%	69

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Pensionfund Sabic's REGN Position: Q3 2022 in Review

Pensionfund Sabic sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 2,800 shares — an estimated $1.66M sold.

Pensionfund Sabic first reported a position in REGN in Q4 2018 and held it in 6 quarters. The position peaked at $2.65M in Q4 2021. 1,080 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

Pensionfund Sabic reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Pensionfund Sabic sold 2,800 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $1.66M.
Pensionfund Sabic first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 6 quarters.
Pensionfund Sabic's Regeneron Pharmaceuticals position peaked at $2.65M in Q4 2021.
1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Pensionfund Sabic's 13F filing for Q3 2022, filed 3 Oct 2022.